An Analysis of Infectious Failures in Acute Cholangitis

Jesse Thompson, Robert S. Bennion, Henry A. Pitt

Research output: Contribution to journalArticle

Abstract

To determine the factors responsible for therapeutic failures in acute cholangitis, a series of 127 patients was analyzed. There were 64 females and 63 males whose mean age was 57.2 years. Ninetyfour (74.0%) of these patients were clinically cured with initial measures, whereas 33 patients (26%) failed initial therapy for an infectious reason. No differences were observed between the two groups in regard to age and gender. However, more patients in the group that failed had a malignant cause for their bile duct obstruction (72.7% vs. 42.6%, p <0.01) and had a pretreatment positive blood culture (45.5% vs. 13.8%, p <0.01). Patients who failed had a higher mean total bilirubin level (9.7 mg/dl vs. 5.5 mg/dl, p <0.005) and more of them had a level greater than 2.2 mg/dl (97% vs. 69.9%, p <0.001). Also, more bile cultures were initially positive (93.9% vs. 76.6%, p <0.05) and more organisms were isolated per culture (3.88 vs. 2.86, p <0.03) in the patients who failed. In addition, more patients failed who had two or more organisms in the bile (33% vs. 8.3%, p <0.02). Patients in whom Candida, or any panresistant organism was isolated also tended to fail. Multivariant analysis showed that malignancy, bacteremia, bilirubin > 2.2 mg/dl, > 2 organisms in the bile and a panresistant organism were the best predictors of treatment failure with a serum bilirubin level > 2.2 mg/dl being the variable that increases a patient's log-odds ratio of failure the greatest. In conclusion, patients with acute cholangitis who have an increased chance to fail initial therapy can be identified, and treatment altered accordingly.

Original languageEnglish (US)
Pages (from-to)139-145
Number of pages7
JournalHPB Surgery
Volume8
Issue number2
DOIs
StatePublished - 1994

Fingerprint

Cholangitis
Cholestasis
Therapeutics
Treatment Failure
Bilirubin
Bile
Odds Ratio
Serum

Keywords

  • biliary antibiotics
  • biliary infection
  • Cholangitis

ASJC Scopus subject areas

  • Hepatology
  • Surgery

Cite this

Thompson, J., Bennion, R. S., & Pitt, H. A. (1994). An Analysis of Infectious Failures in Acute Cholangitis. HPB Surgery, 8(2), 139-145. https://doi.org/10.1155/1994/73139

An Analysis of Infectious Failures in Acute Cholangitis. / Thompson, Jesse; Bennion, Robert S.; Pitt, Henry A.

In: HPB Surgery, Vol. 8, No. 2, 1994, p. 139-145.

Research output: Contribution to journalArticle

Thompson, J, Bennion, RS & Pitt, HA 1994, 'An Analysis of Infectious Failures in Acute Cholangitis', HPB Surgery, vol. 8, no. 2, pp. 139-145. https://doi.org/10.1155/1994/73139
Thompson, Jesse ; Bennion, Robert S. ; Pitt, Henry A. / An Analysis of Infectious Failures in Acute Cholangitis. In: HPB Surgery. 1994 ; Vol. 8, No. 2. pp. 139-145.
@article{9d0617ca32c7415eae0210d5f688b930,
title = "An Analysis of Infectious Failures in Acute Cholangitis",
abstract = "To determine the factors responsible for therapeutic failures in acute cholangitis, a series of 127 patients was analyzed. There were 64 females and 63 males whose mean age was 57.2 years. Ninetyfour (74.0{\%}) of these patients were clinically cured with initial measures, whereas 33 patients (26{\%}) failed initial therapy for an infectious reason. No differences were observed between the two groups in regard to age and gender. However, more patients in the group that failed had a malignant cause for their bile duct obstruction (72.7{\%} vs. 42.6{\%}, p <0.01) and had a pretreatment positive blood culture (45.5{\%} vs. 13.8{\%}, p <0.01). Patients who failed had a higher mean total bilirubin level (9.7 mg/dl vs. 5.5 mg/dl, p <0.005) and more of them had a level greater than 2.2 mg/dl (97{\%} vs. 69.9{\%}, p <0.001). Also, more bile cultures were initially positive (93.9{\%} vs. 76.6{\%}, p <0.05) and more organisms were isolated per culture (3.88 vs. 2.86, p <0.03) in the patients who failed. In addition, more patients failed who had two or more organisms in the bile (33{\%} vs. 8.3{\%}, p <0.02). Patients in whom Candida, or any panresistant organism was isolated also tended to fail. Multivariant analysis showed that malignancy, bacteremia, bilirubin > 2.2 mg/dl, > 2 organisms in the bile and a panresistant organism were the best predictors of treatment failure with a serum bilirubin level > 2.2 mg/dl being the variable that increases a patient's log-odds ratio of failure the greatest. In conclusion, patients with acute cholangitis who have an increased chance to fail initial therapy can be identified, and treatment altered accordingly.",
keywords = "biliary antibiotics, biliary infection, Cholangitis",
author = "Jesse Thompson and Bennion, {Robert S.} and Pitt, {Henry A.}",
year = "1994",
doi = "10.1155/1994/73139",
language = "English (US)",
volume = "8",
pages = "139--145",
journal = "HPB Surgery",
issn = "0894-8569",
publisher = "Hindawi Publishing Corporation",
number = "2",

}

TY - JOUR

T1 - An Analysis of Infectious Failures in Acute Cholangitis

AU - Thompson, Jesse

AU - Bennion, Robert S.

AU - Pitt, Henry A.

PY - 1994

Y1 - 1994

N2 - To determine the factors responsible for therapeutic failures in acute cholangitis, a series of 127 patients was analyzed. There were 64 females and 63 males whose mean age was 57.2 years. Ninetyfour (74.0%) of these patients were clinically cured with initial measures, whereas 33 patients (26%) failed initial therapy for an infectious reason. No differences were observed between the two groups in regard to age and gender. However, more patients in the group that failed had a malignant cause for their bile duct obstruction (72.7% vs. 42.6%, p <0.01) and had a pretreatment positive blood culture (45.5% vs. 13.8%, p <0.01). Patients who failed had a higher mean total bilirubin level (9.7 mg/dl vs. 5.5 mg/dl, p <0.005) and more of them had a level greater than 2.2 mg/dl (97% vs. 69.9%, p <0.001). Also, more bile cultures were initially positive (93.9% vs. 76.6%, p <0.05) and more organisms were isolated per culture (3.88 vs. 2.86, p <0.03) in the patients who failed. In addition, more patients failed who had two or more organisms in the bile (33% vs. 8.3%, p <0.02). Patients in whom Candida, or any panresistant organism was isolated also tended to fail. Multivariant analysis showed that malignancy, bacteremia, bilirubin > 2.2 mg/dl, > 2 organisms in the bile and a panresistant organism were the best predictors of treatment failure with a serum bilirubin level > 2.2 mg/dl being the variable that increases a patient's log-odds ratio of failure the greatest. In conclusion, patients with acute cholangitis who have an increased chance to fail initial therapy can be identified, and treatment altered accordingly.

AB - To determine the factors responsible for therapeutic failures in acute cholangitis, a series of 127 patients was analyzed. There were 64 females and 63 males whose mean age was 57.2 years. Ninetyfour (74.0%) of these patients were clinically cured with initial measures, whereas 33 patients (26%) failed initial therapy for an infectious reason. No differences were observed between the two groups in regard to age and gender. However, more patients in the group that failed had a malignant cause for their bile duct obstruction (72.7% vs. 42.6%, p <0.01) and had a pretreatment positive blood culture (45.5% vs. 13.8%, p <0.01). Patients who failed had a higher mean total bilirubin level (9.7 mg/dl vs. 5.5 mg/dl, p <0.005) and more of them had a level greater than 2.2 mg/dl (97% vs. 69.9%, p <0.001). Also, more bile cultures were initially positive (93.9% vs. 76.6%, p <0.05) and more organisms were isolated per culture (3.88 vs. 2.86, p <0.03) in the patients who failed. In addition, more patients failed who had two or more organisms in the bile (33% vs. 8.3%, p <0.02). Patients in whom Candida, or any panresistant organism was isolated also tended to fail. Multivariant analysis showed that malignancy, bacteremia, bilirubin > 2.2 mg/dl, > 2 organisms in the bile and a panresistant organism were the best predictors of treatment failure with a serum bilirubin level > 2.2 mg/dl being the variable that increases a patient's log-odds ratio of failure the greatest. In conclusion, patients with acute cholangitis who have an increased chance to fail initial therapy can be identified, and treatment altered accordingly.

KW - biliary antibiotics

KW - biliary infection

KW - Cholangitis

UR - http://www.scopus.com/inward/record.url?scp=0028598224&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028598224&partnerID=8YFLogxK

U2 - 10.1155/1994/73139

DO - 10.1155/1994/73139

M3 - Article

C2 - 7880773

AN - SCOPUS:0028598224

VL - 8

SP - 139

EP - 145

JO - HPB Surgery

JF - HPB Surgery

SN - 0894-8569

IS - 2

ER -